When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alcohol use disorder

ბოლო მიმოხილვა: 11 May 2026
ბოლო განახლება: 25 Sep 2025

შეჯამება

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • withdrawal
  • tolerance
  • increased/decreased liver size, jaundice, ascites
Todos los datos

Otros factores de diagnóstico

  • insomnia
  • erectile dysfunction
  • nicotine use disorder
  • gastrointestinal distress
  • muscle cramps, pain, tenderness, altered sensory perception
  • hypertension and tachycardia
  • impaired nutritional status
  • broad-based gait
Todos los datos

Factores de riesgo

  • family history of alcohol use disorder
  • depression, anxiety, and other mental health disorders
  • socioeconomic deprivation
  • lack of facial flushing on exposure to alcohol
  • low responsivity to the effects of alcohol
  • history of gastric bypass
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • diagnostic interview
  • alcohol level (breath and blood)
  • Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • carbohydrate-deficient transferrin (CDT)
  • gamma glutamyl transpeptidase (gamma-GT), alanine aminotransferase (ALT), aspartate aminotransferase (AST)
  • CBC
  • urinary ethyl glucuronide
  • phosphatidylethanol (PEth)
Todos los datos

Algoritmo de tratamiento

En curso

at-risk drinking

alcohol use disorder: nonpregnant adult with no concurrent opioid use or mental health diagnosis

alcohol use disorder: nonpregnant adult with concurrent opioid use

alcohol use disorder: nonpregnant adult with concurrent mental health diagnosis

alcohol use disorder: nonpregnant adolescent

alcohol use disorder: pregnant

Colaboradores

Autores

Elisabeth Poorman, MD, MPH

Assistant Professor of Medicine

Department of Medicine

University of Illinois Chicago

Chicago

IL

Divulgaciones

EP declares that she has no conflicting interests.

Marlene Martin, MD

Associate Professor of Clinical Medicine

Director, Addiction Care Team

San Francisco General Hospital

University of California, San Francisco

San Francisco

CA

Declarações

MM is a board member for the National Harm Reduction Coalition and has done consultancy work for the Society of Hospital Medicine.

Sarah Messmer, MD

Assistant Professor of Clinical Medicine and Pediatrics

University of Illinois Chicago

Chicago

IL

Declarações

SM declares that she has no conflicting interests.

Agradecimentos

Dr Elisabeth Poorman, Dr Marlene Martin, and Dr Sarah Messmer would like to gratefully acknowledge Dr Colin Drummond, Dr Julie R. Pittman, Dr Philip H. Chung, Dr Robert M. Swift, and Dr Lorenzo Leggio, previous contributors to this topic.

Declarações

CD, JRP, PHC, and RMS declare that they have no competing interests. LL is an author of a reference cited in this topic.

Revisores

Stephen Holt, MD, MS

Associate Professor of Medicine

Yale School of Medicine

New Haven

CT

Declarações

SH declares that they have no competing interests.

Bhanu Prakash Kolla, MD, FRCPsych

Professor of Psychiatry

Department of Psychiatry and Psychology

Addiction Psychiatrist and Sleep Physician

Center for Sleep Medicine, Mayo Clinic

Rochester

MN

Declarações

BPK declares that they have no competing interests.

Paul S. Haber, MD

Royal Prince Alfred Hospital and Discipline of Medicine

University of Sydney

Sydney

Australia

Declarações

PSH is an author of a reference cited in this topic.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American Society of Addiction Medicine. Engagement and retention of nonabstinent patients in substance use treatment: clinical consideration for addiction treatment providers. Oct 2024 [internet publication].Texto completo

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

World Health Organization. International classification of diseases,​ 11th revision (ICD-11). Feb 2025 [internet publication].Texto completo

US Department of Veterans Affairs. VA/DOD clinical practice guidelines: management of substance use disorders. 2021​ [internet publication].Texto completo

Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Other psychiatric disorders
    • Other substance use disorders (especially sedatives)
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR)
    • Management of substance use disorders: guidelines from the VA/DoD
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Alcohol-use disorder

    Mais Folhetos informativos para os pacientes
  • Calculadoras

    Alcohol Consumption Screening AUDIT Questionnaire

    Mais Calculadoras
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal